School of Medicine
Showing 4,021-4,040 of 5,029 Results
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Ripal Shah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRipal Shah, M.D., M.P.H. is a Clinical Associate Professor at the Stanford University School of Medicine. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry. Dr. Shah is board certified in Adult Psychiatry, Addiction Medicine, Obesity Medicine, and Integrative Medicine, and is board-eligible in Longevity Medicine. She specializes clinically in the care of women, high performers, and those seeking non-pharmaceutical approaches to health.
Dr. Shah's clinical expertise are in reproductive psychiatry (pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), sexual health disorders, menopause), lifestyle and integrative approaches to health (vitamins, supplements, exercise, behavioral change, hypnosis, longevity), and in high performers such as physicians and CEOs. She leads the Longevity Medicine, Weight Management, and Integrative Mental Health programs in the Stanford Center for Integrative Medicine. Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.
Her research areas of focus are on women's reproductive psychiatry, evidence-based longevity medicine, ethnicity-dependent variability in mental health access and treatment response, psychedelics, the role of Eastern religions on mental health in the U.S., and how psychological science can help us overcome the loneliness epidemic. Outside of consultations, she specializes in psychotherapy for those struggling with relationships or loss of a partnership; grief or loss of a parent, sibling, child, or spouse; issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation); as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.
While in training at Stanford, Dr. Shah served as Chief Resident and led community partnerships. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes in over 20 countries. She founded the Diversity & Inclusion Advisory Council (DIAC), now implemented at psychiatry programs across the country, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership.
Dr. Shah pursued additional training in the fields of Emergency Medicine and Internal Medicine. She has been credentialed in TMS, ECT, hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD).
Dr. Shah serves as a clinical advisor for several start-ups and large companies, advises research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has given talks all over the world, from physician-scientist audiences, to C-suite retreats. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape. -
Sajan Shah, MD, MBA
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Sajan Shah is a board-certified, fellowship-trained pain management specialist with the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine.
Dr. Shah specializes in managing acute and chronic pain. He commonly cares for people living with complex spinal conditions that have not responded to conventional treatment. He offers a range of injections to manage pain, including joint corticosteroid injections, peripheral nerve blocks, trigger point injections, and Botox injections for migraines and dystonia. He has experience with neuromodulation techniques, including spinal cord stimulation and peripheral nerve stimulation, and minimally invasive spinal procedures. He strives to provide effective pain therapies that improve the everyday function and quality of life of his patients.
Dr. Shah’s research has explored topics in anesthesiology and pain medicine. He has studied chronic pain syndromes, including how to diagnose and manage rare pain conditions. Dr. Shah has published his findings in several peer-reviewed journals and co-authored a book chapter on complex regional pain syndrome. He has presented his research at national and international meetings, including those held by the American Academy of Pain Medicine, American Society of Regional Anesthesia and Pain Medicine, and North American Neuromodulation Society. -
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, bladder, kidney, and testicular cancers. He is actively involved in clinical trials, with a particular focus on novel immunotherapy agents and biomarkers to select patients most likely to benefit from therapy. His academic interests also encompass digital health technologies and innovative healthcare delivery models. He has lectured internationally on the management of urologic cancers and currently serves on the National Cancer Center Network (NCCN) Panel for testicular cancer.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Healthcare Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioI lead a computational oncology laboratory that develops machine learning and statistical methods for high-dimensional genomics, with particular expertise in Bayesian and uncertainty-aware modeling to integrate prior biological knowledge with large-scale datasets.
Our research centers on liquid biopsy analytics—especially cell-free DNA (cfDNA)—to noninvasively quantify genetic and epigenetic states relevant to cancer detection, monitoring, and tumor evolution. We developed EPIC-seq, a fragmentomics-based method that uses cfDNA fragmentation patterns to infer regulatory activity and gene expression programs, providing a scalable framework for epigenetic profiling from blood.
A core methodological focus of the lab is enabling reliable inference in extremely low signal-to-noise settings that are typical of cfDNA and early-stage disease. We build robust, interpretable models and benchmarking frameworks that support clinical translation, with the long-term aim of democratizing access to sensitive, minimally invasive cancer diagnostics. -
Mehrdad Shamloo
Professor (Research) of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe ultimate goal of the Shamloo laboratory is to rapidly advance our understanding of brain function at the molecular, cellular, circuit and behavioral levels, and to elucidate the pathological process underlying malfunction of the nervous system following injury and neurologic disorders such as stroke, Alzheimer's disease, Parkinson’s disease, and autism. We have been focusing on the noradrenergic system and approaches leading to restoration of brain adrenergic signaling in these disorders.
-
Hua Shan
Professor of Pathology
BioDr. Shan specializes in providing blood transfusion and apheresis treatment to patients with diverse medical problems. She has been practicing transfusion medicine for over thirty years. Dr. Shan served as the Medical Director of Transfusion Service at Stanford Medical Center from 2015 to 2026. Dr. Shan has also been leading research and education programs in the fields of transfusion safety, optimizing clinical blood transfusion practice and blood availability.
-
Vikram Shankar, MD
Clinical Instructor, Ophthalmology
BioDr. Shankar, MD, MPH, is a board-certified, fellowship-trained ophthalmologist at the Stanford Health Care Byers Eye Institute. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Shankar’s clinical focus is the medical and surgical care of cataracts and adult glaucoma, including premium lenses and minimally invasive glaucoma surgery (MIGS). Dr. Shankar’s research and professional interests include ophthalmic public health, biomedical devices, and digital health. He has a particular interest in the intersection of entrepreneurship, public health, and ophthalmology, aiming to find innovative solutions that will impact millions of patients.
Dr. Shankar has published research on lung cancer metastasis to the optic nerve, pharmacologic therapies in glaucoma, and surgical outcomes with a novel glaucoma device. He has also delivered presentations nationwide on topics including screening rates for diabetic retinopathy based on insurance type and socioeconomic factors, Medicaid expansion, and health disparities.
Dr. Shankar completed a combined MD/MPH at Washington University in St. Louis School of Medicine. He earned the Albert F. Koetter, MD Scholarship; Dean’s Research Fellowship; and Jonathan Mann Fellowship as a medical student. He completed his ophthalmology residency at the Wills Eye Hospital in Philadelphia, PA. He subsequently completed his fellowship in glaucoma at the Stanford Byers Eye Institute.
Dr. Shankar is the cofounder of a seed-stage ophthalmic medical device startup that aims to improve patient safety and mitigate the environmental impact of eye care worldwide.
Dr. Shankar is a member of the American Academy of Ophthalmology. -
Lucy Shapiro
Virginia and D. K. Ludwig Professor, Emerita
Current Research and Scholarly InterestsA basic question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code. Our goal is to define these mechanisms using both molecular genetics and biochemistry.
